Trial Profile

A phase I trial assessing IFM-2427 in healthy volunteers

Status: Recruiting

Phase of Trial: Phase I

Latest Information Update: 19 Jul 2019

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs DFV 890 (Primary)
Indications Inflammation
Focus First in man; Therapeutic Use
Sponsors IFM therapeutics; Novartis

Most Recent Events

03 Apr 2019 New trial record
28 Mar 2019 According to a IFM Therapeutics media release, the company announced that the first subjects have been dosed for this study.This study is expected to complete in the fourh quarter of 2019.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com